Welcome to the tag category page for Medical technology!
Continuous Glucose Monitoring (CGM) is a device that automatically tracks blood glucose levels throughout the day and night, giving insights into where glucose levels were, where they are, and where they are headed. CGM systems use a tiny sensor inserted under the skin on the abdomen or arm that tracks glucose levels every few minutes. It is approved for use by adults and children with a prescription and is recommended for patients on intensive insulin therapy. The average starting cost for a CGM system is around $1,000, and Medicare covers it through the durable medical equipment benefit. The major limitation of CGM is the measurement of interstitial glucose levels rather than real-time blood glucose levels, which causes a delay in treatment for hyperglycemia and hypoglycemia in patients.
Sinus rhythm refers to the normal heartbeat rhythm that originates from the sinus node in the heart. It is characterized by a regular heartbeat with a rate of 60 to 100 bpm in adults. Sinus arrhythmia may also occur, which is an irregular rhythm with greater than 10% variation in the P-P interval. However, this type of arrhythmia is not dangerous and is a sign of a healthy heart. Normal sinus rhythm is associated with a regular ECG pattern, with normal P waves and ECG measurements. Overall, sinus rhythm is an important aspect of a healthy heart and its proper functioning.
Semaglutide Injection is a medication used to treat type 2 diabetes and control blood sugar levels. It can also help lower the risk of heart attack, stroke, or death in patients with type 2 diabetes and heart or blood vessel disease. The medication is given once a week by injection under the skin of the thigh, stomach area, or upper arm. However, Semaglutide Injection comes with potential risks, such as an increased risk of developing tumors of the thyroid gland. Semaglutide Injection has also been shown to be effective in treating obesity and promoting weight loss. Studies have demonstrated weight loss of 6% to 12% within 12 to 28 weeks. While the medication may not provide immediate weight loss, it works quickly, with studies showing a reduction in body weight of over 2% within four weeks of taking Semaglutide Injection. The medication is relatively affordable, costing between $149 and $399 for a one-month supply depending on the dose. It is important for patients to consult with their healthcare provider about potential risks and benefits prior to use. Overall, Semaglutide Injection is a valuable tool in the treatment of type 2 diabetes and obesity.
Zelis is a company that specializes in modernizing the healthcare financial experience through data, insights, and solutions. They offer a connected platform that enables users to identify, optimize, and solve problems holistically. Zelis provides claims cost and payments optimization solutions to healthcare providers and payers. The company also offers medical billing software called Zelis Payments, which allows businesses to track sales data and accept payments in one place. Zelis is not a health insurance company, but they work with healthcare stakeholders to simplify the financial experience for all. Enrolling for ERAs with Zelis Payments is free and can be done online. David Zelis, MD, is a Pediatrics physician at WellSpan Pediatric Medicine - South Queen Street, York, PA, but it is unknown if he is related to Zelis, the company.
Dulaglutide, also known as Trulicity, is a medication used to treat type 2 diabetes. It is a once-weekly injectable prescription medicine that improves blood sugar levels in adults with type 2 diabetes. Dulaglutide is used together with diet and exercise to control blood sugar. It is a subcutaneous glucagon-like peptide-1 (GLP-1) receptor agonist designed using recombinant DNA technology. It is similar to a natural hormone in the body known as incretin, and it works by causing insulin release in response to high blood sugar levels. Common side effects include nausea, diarrhea, vomiting, abdominal pain, decreased appetite, indigestion, and fatigue. Dulaglutide should only be used under the guidance and supervision of a healthcare provider.
Transferrin saturation is a medical laboratory value that is measured as a percentage. It is the ratio of serum iron concentration and total iron-binding capacity expressed as a percentage. Transferrin saturation is used to detect iron deficiency or overload in the body. Transferrin saturation values of less than 20% suggest iron deficiency, while those of more than 50% indicate iron overload. If transferrin saturation is high, it may be a sign of hemochromatosis, a condition in which the body absorbs too much iron. Transferrin saturation is influenced by liver disease and inflammation, and other tests should be performed to confirm a diagnosis.
Ozempic is a once-weekly injection medication used to improve blood sugar levels in adults with type 2 diabetes when used alongside diet and exercise. It stimulates insulin secretion to lower fasting and postprandial blood glucose. Another brand of semaglutide, Wegovy, is approved for weight loss, but Ozempic is not. Ozempic and metformin are both antidiabetic medications that control blood sugar. Side effects may include nausea, vomiting, diarrhea, and abdominal pain. Developed by Novo Nordisk in 2012, it is an antidiabetic medication also used as an anti-obesity medication for long-term weight management.
Fertility benefits refer to employer-provided coverage for individuals seeking fertility treatments, including diagnostic and treatment services. These benefits can include coverage for infertility diagnosis, medication, in-vitro fertilization, and support for adoption and surrogacy. Companies are increasingly investing in fertility benefits to reduce costs, expand their commitment to diversity, equity, and inclusion, and attract and retain top talent. Fertility benefits are not usually a separate health insurance policy but are covered under healthcare plans by many health insurers. Some states, such as California and New York, mandate fertility preservation coverage.
